BLU News and Press, BELLUS Health Inc. From 09/21/21

Gainers: MRIN +72.9%. ALPN +22.5%. SFIX +12.8%. PRAX +5.4%. LAUR +3.3%. Losers: SMMT -19.8%. LPTX -11.4%. BDSI -8.8%. BLU -5.2%. ATAX -4.2%. For further details see: MRIN, ALPN, SMMT and LPTX among after hours movers

Healthcare stocks in the S&P 500 edged past the ~0.6% loss in the broader index over the week to end ~0.2% lower, becoming the fourth best performing sector. Among stocks with more than $300M market cap and over 100K average daily volume over the past five sessions, BELLUS Health (NA...

The following slide deck was published by BELLUS Health Inc. in conjunction with this event. For further details see: BELLUS Health (BLU ) Investor Presentation - Slideshow

Although markets have been strong lately and many stocks are at or near their 52-week high, there are still plenty of high-quality Canadian stocks to consider today. Many growth stocks offer investors attractive opportunities, and these companies all come from several industries differe...

A $12B merger highlighted Tuesday's midday trading, as Intuit (NASDAQ:INTU) reached a deal to buy Mailchimp. Comcast (NASDAQ:CMCSA) represented another high-profile name making headlines. The stock dipped after the company's CFO tempered expectations for subscriber additions. Mission Produce ...

Gainers: Communications Systems (NASDAQ:JCS) +33%. BELLUS Health (NASDAQ:BLU) +20%. Matinas BioPharma (NYSE:MTNB) +19%. Onion Global (NYSE:OG) +18%. FuelCell Energy (NASDAQ:FCEL) +17%. Silverback Therapeutics (NASDAQ:SBTX) +16%. DatChat (NASDAQ:DATS) +15%. Calumet (NASDAQ:CLMT) +15%. Ada...

Shares of BELLUS Health (TSX:BLU) (NASDAQ:BLU) went gangbusters on the TSX today after management announced “positive findings” in a treatment for refractory chronic cough (RCC). Shares of the company jumped 30% by early Tuesday afternoon and continue to climb....

Gainers: BELLUS Health (NASDAQ:BLU) +26%, aTyr Pharma (NASDAQ:LIFE) +22%, Jounce Therapeutics (NASDAQ:JNCE) +14%, NanoViricides (NYSE:NNVC) +12%, Matinas BioPharma (NYSE:MTNB) +12%. Losers: Virpax Pharmaceuticals (NASDAQ:VRPX) -37%, RedHill Bi...

Gainers: Itamar (NASDAQ:ITMR) +46%. Aterian (NASDAQ:ATER) +40%. aTyr Pharma (NASDAQ:LIFE) +37%. iRhythm Technology (NASDAQ:IRTC) +34%. BELLUS (NASDAQ:BLU) +26%. Leap Therapeutics  (NASDAQ:LPTX) +30%. REGENXBIO (NASDAQ:RGNX) +25%. Datasea (NASDAQ:DTSS) +20%. Uranium Royalty (NASDAQ:UROY) ...

Itamar Medical (NASDAQ:ITMR) +44% on being taken over by Zoll Medical for ~$538M Leap Therapeutics (NASDAQ:LPTX) +42% to present new data from the DisTinGuish study of DKN-01 Plus Tislelizumab at the ESMO 2021 Congres BELLUS Health (NASDAQ:BLU) +24% positive interim f...